论文部分内容阅读
为了研究急性乙型肝炎患者的抗丙型肝炎病毒(HCV)阳性率及其临床意义,作者用第二代抗-HCV ELISA试剂盒(Ortho)检测抗-HCV,并用第二代重组免疫斑点试验(RIBA-2)加以确证。在121例自限性急性乙型肝炎患者中,男性84人(69.4%),女性37人(30.6%),平均年龄30.1±14.9岁。静脉毒瘾者(IVDA)63人,平均吸毒时间为24.2±18个月。急性乙型肝炎的诊断是根据临床特点,丙氨酸转氨酶(ALT)至少高于正常值10倍和抗-HBc IgM阳性。病人的双份血清
To investigate the anti-HCV positive rate and its clinical significance in patients with acute hepatitis B, the authors used anti-HCV second-generation anti-HCV ELISA kit (Ortho) to detect anti-HCV and used the second generation of recombinant immune spot test (RIBA-2) to confirm. Among 121 self-limited acute hepatitis B patients, 84 (69.4%) were males and 37 (30.6%) were females, with an average age of 30.1 ± 14.9 years. 63 were intravenous addicts (IVDA), with an average of 24.2 ± 18 months. Acute hepatitis B is diagnosed based on clinical characteristics, alanine aminotransferase (ALT) at least 10 times higher than normal and anti-HBc IgM positive. Patient’s double serum